1,447.15
+20.55
+(1.44%)
As of 2:52:48 PM GMT+5:30. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
57,060,550
56,417,320
35,918,590
43,841,450
34,236,370
Cost of Revenue
22,018,110
21,730,880
16,854,270
21,092,170
14,918,740
Gross Profit
35,042,440
34,686,440
19,064,320
22,749,280
19,317,630
Operating Expense
25,913,220
24,725,520
10,197,880
8,745,520
7,280,420
Operating Income
9,129,220
9,960,920
8,866,440
14,003,760
12,037,210
Net Non Operating Interest Income Expense
1,060,970
1,244,050
1,719,700
1,334,030
825,380
Pretax Income
10,725,550
11,325,420
10,545,820
16,185,520
13,348,100
Tax Provision
3,681,500
3,600,820
2,735,390
4,068,880
3,378,470
Net Income Common Stockholders
7,044,050
7,724,600
7,810,430
12,116,640
9,969,630
Diluted NI Available to Com Stockholders
7,044,050
7,724,600
7,810,430
12,116,640
9,969,630
Basic EPS
42.76
46.90
47.44
73.81
63.07
Diluted EPS
42.76
46.89
47.43
73.64
62.99
Basic Average Shares
164,732.80
164,702.19
164,636.95
164,153.03
158,076.91
Diluted Average Shares
164,732.80
164,733.25
164,679.74
164,537.78
158,278.17
Rent Expense Supplemental
--
99,240
14,160
11,180
8,240
Total Expenses
47,931,330
46,456,400
27,052,150
29,837,690
22,199,160
Net Income from Continuing & Discontinued Operation
7,044,050
7,724,600
7,810,430
12,116,640
9,969,630
Normalized Income
7,089,943.98
7,772,265.15
8,271,305.38
12,086,928.07
9,971,512.19
Interest Income
--
1,506,050
1,794,170
1,386,450
859,490
Interest Expense
400,980
217,900
62,870
34,020
29,110
Net Interest Income
1,060,970
1,244,050
1,719,700
1,334,030
825,380
EBIT
11,126,530
11,543,320
10,608,690
16,219,540
13,377,210
EBITDA
14,873,750
14,988,980
12,076,050
17,322,500
14,365,010
Reconciled Cost of Revenue
22,018,110
21,730,880
16,854,270
21,092,170
14,918,740
Reconciled Depreciation
3,747,220
3,445,660
1,467,360
1,102,960
987,800
Net Income from Continuing Operation Net Minority Interest
7,044,050
7,724,600
7,810,430
12,116,640
9,969,630
Total Unusual Items Excluding Goodwill
-69,880
-69,880
-622,300
39,690
-2,520
Total Unusual Items
-69,880
-69,880
-622,300
39,690
-2,520
Normalized EBITDA
14,943,630
15,058,860
12,698,350
17,282,810
14,367,530
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-23,986.02
-22,214.85
-161,424.62
9,978.07
-637.81
3/31/2021 - 11/20/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NEULANDLAB.BO Neuland Laboratories Limited
12,725.00
+0.55%
SUVEN.NS Suven Life Sciences Limited
126.04
-1.20%
PARMAX.BO Parmax Pharma Limited
43.00
-0.58%
BAJAJHCARE.BO Bajaj HealthCare Limited
624.30
+0.39%
AARTIPHARM.BO Aarti Pharmalabs Limited
712.00
-0.05%
HIKAL.BO Hikal Limited
435.25
+5.05%
ANUHPHR.BO Anuh Pharma Limited
173.35
-0.43%
GRANULES.BO Granules India Limited
462.00
-0.51%
FDC.NS FDC Limited
429.00
+0.94%
GLENMARK.BO Glenmark Pharmaceuticals Limited
1,355.20
-1.47%